Jump to content
bristoldrv

Mak Capital One Increases Position in Achillion Pharmaceuticals In (ACHN); Bristol John W & Company Trimmed Nike (NKE) Stake by $308532; Valuation Declined - The InvestReporter

Recommended Posts

Mak Capital One Increases Position in Achillion Pharmaceuticals In (ACHN); Bristol John W & Company Trimmed Nike (NKE) Stake by $308532; Valuation Declined  The InvestReporter

Mak Capital One Llc increased its stake in Achillion Pharmaceuticals In (ACHN) by 33.48% based on its latest 2019Q1 regulatory filing with the SEC.

View the full article

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...


×